Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Apatinib as Maintenance Therapy After First-line Chemotherapy(DC for 4 Cycles) in Postoperative Recurrence/Metastasis Progressive Gastric Cancer

NCT02509806 is registered in ClinicalTrials.gov with Hebei Medical University as lead sponsor.

NCT NCT02509806
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02509806 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Apatinib as Maintenance Therapy After First-line Chemotherapy(DC for 4 Cycles) in Postoperative Recurrence/Metastasis Progressive Gastric Cancer
Lead sponsor
Hebei Medical University
Phase
Phase 2/3
Overall status
Unknown status
Start date
July 31, 2015
Completion date
December 31, 2017
Enrollment
48 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastric cancer